StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.20+0.01 (+0.08%)

Close on Nov 18, 2026Market cap $136.43MP/E –Yield 0.00%

Medifast operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Medifast's operating income for the twelve months ending Sep 30, 2026 was -$34.78M. For fiscal 2025 it was -$14.21M, down 593.8% from the year before. The highest annual figure on record is $216.24M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.21M-593.8%
FY2024Dec 31, 2024$2.88M-97.7%
FY2023Dec 31, 2023$126.40M-31.6%
FY2022Dec 31, 2022$184.81M-14.5%
FY2021Dec 31, 2021$216.24M+61.2%
FY2020Dec 31, 2020$134.16M+47.4%
FY2019Dec 31, 2019$91.04M+31.8%
FY2018Dec 31, 2018$69.06M+74.3%
FY2017Dec 31, 2017$39.63M+47.6%
FY2016Dec 31, 2016$26.86M-6.4%
FY2015Dec 31, 2015$28.68M-5.2%
FY2014Dec 31, 2014$30.25M-21.3%
FY2013Dec 31, 2013$38.41M+41.5%
FY2012Dec 31, 2012$27.14M-0.9%
FY2011Dec 31, 2011$27.38M-13.5%
FY2010Dec 31, 2010$31.64M+71.1%
FY2009Dec 31, 2009$18.50M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$19.36M–
Q2 FY2026Jun 30, 2026-$4.33M–
Q1 FY2026Mar 31, 2026-$3.30M–
Q4 FY2025Dec 31, 2025-$7.80M-1200.6%
Q3 FY2025Sep 30, 2025-$4.08M-293.8%
Q2 FY2025Jun 30, 2025-$1.07M–
Q1 FY2025Mar 31, 2025-$1.26M-115.9%
Q4 FY2024Dec 31, 2024$709.00K-91.8%
Q3 FY2024Sep 30, 2024$2.11M-91.7%
Q2 FY2024Jun 30, 2024-$7.88M-120.3%
Q1 FY2024Mar 31, 2024$7.94M-85.2%
Q4 FY2023Dec 31, 2023$8.68M-73.4%
Q3 FY2023Sep 30, 2023$25.51M-47.0%
Q2 FY2023Jun 30, 2023$38.71M-21.0%
Q1 FY2023Mar 31, 2023$53.51M-2.9%
Q4 FY2022Dec 31, 2022$32.60M-30.4%
Q3 FY2022Sep 30, 2022$48.16M-12.7%
Q2 FY2022Jun 30, 2022$48.96M-20.3%
Q1 FY2022Mar 31, 2022$55.09M+4.3%
Q4 FY2021Dec 31, 2021$46.84M+23.4%
Q3 FY2021Sep 30, 2021$55.17M+23.8%
Q2 FY2021Jun 30, 2021$61.43M+118.6%
Q1 FY2021Mar 31, 2021$52.80M+124.4%
Q4 FY2020Dec 31, 2020$37.97M+103.0%
Q3 FY2020Sep 30, 2020$44.56M+119.9%
Q2 FY2020Jun 30, 2020$28.10M+2.7%
Q1 FY2020Mar 31, 2020$23.53M-4.8%
Q4 FY2019Dec 31, 2019$18.71M-5.5%
Q3 FY2019Sep 30, 2019$20.26M+16.0%
Q2 FY2019Jun 30, 2019$27.36M+59.9%
Q1 FY2019Mar 31, 2019$24.72M+68.3%
Q4 FY2018Dec 31, 2018$19.80M+108.8%
Q3 FY2018Sep 30, 2018$17.47M+70.8%
Q2 FY2018Jun 30, 2018$17.11M+51.3%
Q1 FY2018Mar 31, 2018$14.68M+70.6%
Q4 FY2017Dec 31, 2017$9.49M+43.4%
Q3 FY2017Sep 30, 2017$10.23M–
Q2 FY2017Jun 30, 2017$11.31M–
Q1 FY2017Mar 31, 2017$8.61M–
Q4 FY2016Dec 31, 2016$6.61M–

More Medifast figures

See a number that looks wrong?